Edmonton Obesity Staging System: Post-operative Outcome and 30-day Mortality
NCT ID: NCT02607267
Last Updated: 2018-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
534 participants
OBSERVATIONAL
2014-10-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Procedure Selection in Obesity and Metabolic Surgery Based on EOSS
NCT03556059
Metabolomics and Bariatric Surgery in Patients With Metabolically Unhealthy Obesity
NCT06297928
Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery
NCT03391401
Molecular, Metabolomic and Nutritional Changes After Metabolic Surgery
NCT05322551
Comparative Effectiveness of Metabolic and Bariatric Surgery With PROMs
NCT02749305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
laparoscopic Roux en Y Gastric Bypass
patients undergoing LRYGB, being the first surgical treatment for severe obesity
LSG and LRYGB
The role of the Edmonton Obesity Staging System in predicting post-operative outcome and 30-day mortality after metabolic surgery (LSG and LRYGB)
laparoscopic Sleeve Gastrectomy
patients undergoing LSG, being the first surgical treatment for severe obesity
LSG and LRYGB
The role of the Edmonton Obesity Staging System in predicting post-operative outcome and 30-day mortality after metabolic surgery (LSG and LRYGB)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LSG and LRYGB
The role of the Edmonton Obesity Staging System in predicting post-operative outcome and 30-day mortality after metabolic surgery (LSG and LRYGB)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
73 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sana Klinikum Offenbach
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sonja Chiappetta, MD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christine Stier, MD
Role: STUDY_DIRECTOR
Sana Klinikum Offenbach
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sana Klinikum Offenbach
Offenbach, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sui X, Blair SN. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab. 2011 Aug;36(4):570-6. doi: 10.1139/h11-058. Epub 2011 Aug 14.
Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011 Oct 4;183(14):E1059-66. doi: 10.1503/cmaj.110387. Epub 2011 Aug 15.
Gill RS, Karmali S, Sharma AM. The potential role of the Edmonton obesity staging system in determining indications for bariatric surgery. Obes Surg. 2011 Dec;21(12):1947-9. doi: 10.1007/s11695-011-0533-8. No abstract available.
Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009 Mar;33(3):289-95. doi: 10.1038/ijo.2009.2. Epub 2009 Feb 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FF 83/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.